Moreover, AD patients show a significant decline in plasma sLRP1 levels, along with increased oxidative modifications, which may be related to reduced hepatic LRP1 synthesis and increased MMP-9-mediated shedding (Gao et al., 2020). This evidence concerns the gene LRP1 and Alzheimer disease.